Learn about this type of non-Hodgkin lymphoma that affects the lymph nodes and can spread to the organs. Find out about symptoms, diagnosis and treatments.
Update Date: 10.04.2026
Peripheral T-cell lymphoma (PTCL) is a fast-growing type of lymphoma. Lymphoma is a cancer that affects the lymphocytes, which are a type of white blood cell. The white blood cells are part of the body's germ-fighting immune system.
There are many types of lymphoma. Lymphoma types are often divided into two categories: Hodgkin lymphoma and non-Hodgkin lymphoma. PTCL is a type of non-Hodgkin lymphoma.
PTCL gets its name from the kind of cell that makes up this cancer. It starts in white blood cells called mature T cells, also known as T lymphocytes. The T cells undergo changes and turn into cancer cells. A cell's DNA holds the instructions that tell the cell what to do and when to die. Because of these DNA changes, the cells stop dying. They usually multiply and form a mass. PTCL typically affects lymph nodes but can spread to any organ, including the liver, spleen, skin, bone marrow and digestive tract, also called the GI tract.
PTCL is not one condition. There are many variations called subtypes that fall under the PTCL umbrella. Similar to other types of lymphoma, PTCL undergoes specific DNA changes that help it hide from the immune system.
Treatment depends on the PTCL subtype and may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, clinical trials and bone marrow transplant, also called bone marrow stem cell transplant.
Symptoms of peripheral T-cell lymphoma (PTCL) vary by subtype. They may include:
Make an appointment with a doctor or other healthcare professional if you have any symptoms that worry you or are not going away.
Peripheral T-cell lymphoma (PTCL) typically forms when germ-fighting white blood cells get changes in their DNA that turn them into cancer cells. The kind of white blood cells involved in PTCL are mature T cells, also called T lymphocytes. A cell's DNA holds the instructions that tell the cell what to do and when to die. Because of these DNA changes, the cells stop dying. Instead, they multiply and spread. Exactly why these DNA changes happen is not known.
Many types of PTCL usually begin in the lymph nodes and can spread to other organs including the liver, spleen, skin, GI tract and bone marrow.
Some PTCL subtypes also may be affected by a weakened immune system, Celiac disease, and infection with viruses such as Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV).
Some peripheral T-cell lymphoma (PTCL) subtypes tend to affect men more than they affect women. Other risk factors may include:
There is no known way to prevent PTCL.
Peripheral T-cell lymphoma (PTCL) may cause complications as the cancer grows and spreads to other areas of the body. Complications vary by subtype and may include:
A peripheral T-cell lymphoma (PTCL) diagnosis often begins with a physical exam. Medical professionals usually look for enlarged lymph nodes in the neck, armpit and groin.
Other tests and procedures include blood tests, imaging tests and taking a sample of tissue for laboratory testing.
A biopsy is needed to diagnose peripheral T-cell lymphoma (PTCL). A biopsy is a procedure to remove a sample of tissue for testing in a lab. Your healthcare professional may take out a small sample or multiple samples of the affected tissue and bone marrow. The sample is tested in a lab to look for cancer cells.
Blood tests can sometimes show whether lymphoma cells are present. Blood tests may be used to test for viruses, including Epstein-Barr virus and human T-cell lymphotrophic virus (HTLV). Blood tests also measure levels of lactate dehydrogenase (LDH), which is often higher in people with lymphoma.
An imaging test takes pictures inside the body. It can show the location and extent of PTCL. Tests may include a CT scan or a positron emission tomography (PET) scan.
Lymphoma cells collected from a biopsy go to a lab for testing. In the lab, experts use specialized tests to look for specific things about the cells. When viewed under a microscope, the cancer cells look different from healthy cells. The healthcare team uses the test results to find out the type of peripheral T-cell lymphoma (PTCL) you have.
To decide whether the cells are PTCL cells, the experts in the lab look for:
Peripheral T-cell lymphoma (PTCL) is not a single condition. There are several subtypes under the PTCL umbrella. Healthcare professionals select treatments based on the PTCL subtype, the stage of the cancer and your overall health.
Since there are many subtypes, the type of first line treatment usually varies. PTCL treatment may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, clinical trials and bone marrow transplant, also called bone marrow stem cell transplant.
Treatments may be more specialized if certain proteins such as CD30 are found on the T lymphocytes.
Chemotherapy treats cancer with strong medicines. There are many types of chemotherapy medicines. Most chemotherapy medicines are given through a vein. Some come in pill form.
Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points in your body.
Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die.
Immunotherapy for cancer is a treatment with medicine that helps the body's immune system fight cancer cells. Typically, the immune system fights off diseases by attacking germs and other cells that shouldn't be in the body. Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells recognize and kill the cancer cells.
A bone marrow transplant, also called a bone marrow stem cell transplant, involves putting healthy bone marrow stem cells into the body. These cells replace cells hurt by chemotherapy and other treatments.
Autologous stem cell transplant and allogeneic stem cell transplant are procedures that can be used for T-cell lymphoma depending on the type of the disease.
It is common for peripheral T-cell lymphoma (PTCL) to come back after treatment. This is known as a relapse. The time it takes for a relapse to happen varies by subtype. After treatment, you have follow-up appointments to monitor for relapse. You may need repeat biopsies and imaging to confirm a relapse.
The cancer prognosis tells you how likely it is that the cancer can be treated successfully. Your healthcare team can get a general sense of your outlook based on your peripheral T-cell lymphoma (PTCL) subtype, its stage and other factors such as your overall health.
PTCL is considered fast growing. It can be hard to diagnose and may not be found until it has spread in your body.
Your healthcare team talks with you about treatment options that can give you the best chance for a desirable outcome.
People who are treated for PTCL also might have a higher chance of getting another cancer of a different type after treatment, sometimes many years later. Those cancers may include lung, brain, kidney, bladder, melanoma, Hodgkin lymphoma and acute nonlymphocytic leukemia.
Speak with your healthcare team about your prognosis if you want to know what to expect. Members of your healthcare team can explain what they consider when thinking about your prognosis.
People with serious illnesses often say they feel worried and stressed about the future. With time, these strategies may help you find comfort:
Ask questions about peripheral T-cell lymphoma (PTCL). Write down questions you have about your cancer. Ask these questions at your next appointment. Also ask your healthcare team for reliable sources where you can get more information.
Knowing more about your cancer and your treatment options may make it easier to make decisions about your care.
Stay connected to friends and family. Keeping in touch with friends and family may give comfort during difficult times.
Your friends and family may ask if there's anything they can do to help you, so think of tasks you might like help with. For example, you may ask for help caring for your home or pets if you are in the hospital.
You may find comfort in the support of a caring group of your friends and family.
Make an appointment with a healthcare professional if you have any symptoms that worry you or are not going away.
If your healthcare professional thinks you might have peripheral T-cell lymphoma (PTCL), you may be referred to a doctor who specializes in diseases that affect blood cells, called a hematologist. If a cancer diagnosis is made, you also may be referred to a doctor who specializes in treating cancer, called an oncologist.
It is helpful to be prepared before you go to your appointment. Here is a starting point for getting ready.
For peripheral T-cell lymphoma (PTCL), some basic questions to ask include:
Other questions could include:
Don't hesitate to ask other questions.
Be prepared to answer questions, such as:
If you're diagnosed with peripheral T-cell lymphoma (PTCL), the next step is to find out how much and where the cancer has spread. This is called the stage. Healthcare professionals may use imaging and biopsies to determine the stage by looking at how big the cancer is, its location and the distance it has traveled from where it first started.
Your healthcare team creates your treatment plan based on the stage. A higher stage number means the cancer is more advanced.
The stages of PTCL typically range from 1 to 4:
Some PTCL subtypes have a bulky stage. Bulky means a large mass, usually around 4 inches (10 cm).
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use